Fig. 01 -

Title Slide

Fig. 02 -

Disclosures

Fig. 03 -

Relevant Questions

Fig. 04 -

Molecular Profiling

Fig. 05 -

Tumor Heterogeneity

Fig. 06 -

Histological Variants

Fig. 07 -

Tumor Development

Fig. 08 -

Prediction

Fig. 09 -

Personalized Treatments

Fig. 10 -

NMIBC and MIBC

Fig. 11 -

Alterations

Fig. 12 -

mRNA Expression

Fig. 13 -

Molecular Subtypes

Fig. 14 -

Overlaps

Fig. 15 -

Molecular Subclassification

Fig. 16 -

High Risk

Fig. 17 -

Interobserver Reproducibility

Fig. 18 -

Molecular Substratification

Fig. 19 -

Curve Analysis

Fig. 20 -

Neoadjuvant therapy

Fig. 21 -

Neoadjuvant chemotherapy

Fig. 22 -

Basal and Luminal

Fig. 23 -

Molecular Subtypes

Fig. 24 -

Impact of Subtypes

Fig. 25 -

Pre-TURB Samples

Fig. 26 -

Overall Survival

Fig. 27 -

Claudin-low and Basal

Fig. 28 -

Which First?

Fig. 29 -

ERBB2

Fig. 30 -

Chemotherapy

Fig. 31 -

Checkpoint Inhibition

Fig. 32 -

Studies

Fig. 33 -

Trials

Fig. 34 -

Monitoring

Fig. 35 -

Strategy

Fig. 36 -

MSK-IMPACT

Fig. 37 -

Epacadostat

Fig. 38 -

Disease Surveillance

Fig. 39 -

Tumour DNA & Characteristics

Fig. 40 -

Cell Free DNA

Fig. 41 -

Gene Sequencing

Fig. 42 -

Associations

Fig. 43 -

Thank You